Allapinin
Allapinin is a medication containing the active ingredient Lappaconitine hydrobromide, used primarily for managing cardiac arrhythmias. It works by stabilizing the heart's electrical activity, helping to maintain a regular heart rhythm. Available in tablet form, Allapinin is typically prescribed to patients who experience irregular heartbeats. The medication is well-regarded for its effectiveness in improving heart rhythm disorders. Patients are advised to follow the prescribed dosage to achieve optimal results. Allapinin is a trusted choice for those seeking reliable management of arrhythmic conditions. Its formulation is designed to support cardiac health while minimizing disruptions in heart function.Active substance:
Lappaconitine hydrobromidePharmachologic effect:
Allapinin is an antiarrhythmic medication that works by stabilizing cardiac cell membranes and prolonging the refractory period, thereby helping to restore normal heart rhythm.Indications:
- Atrial fibrillation
- Atrial flutter
- Paroxysmal supraventricular tachycardia
- Ventricular premature beats
Contraindications:
- Hypersensitivity to lappaconitine or any component of the drug
- Severe heart failure
- Cardiogenic shock
- Severe hypotension
- Bradycardia
- Sinoatrial block
- Atrioventricular block of the second or third degree
- Severe liver or kidney dysfunction
- Pregnancy and lactation
Side effects:
In order of decreasing probability: Dizziness, Headache, Nausea, Vomiting, Allergic reactions, Hypotension, Bradycardia, Atrioventricular block
Dosing and Administration:
The recommended starting dose is 25 mg taken orally every 8 hours. Depending on the patient's response and tolerance, the dose may be increased to 50 mg every 8 hours. The maximum daily dose should not exceed 300 mg. It is advised to take the medication with a full glass of water.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Allapinin
in Cyrillic : Аллапинин
SUBSTANCE
Lappaconitine hydrobromide
DOSAGE FORM
tablets